SANDU PHARMACEUTICALS LTD.
BSE: 524703
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 16.85-10.2% | 18.76+6.5% | 17.62+5.5% | 16.70+18.7% | 14.07-23.4% | 18.37+3.8% | 17.70 |
| Other Income | 0.37+2565.0% | 0.01-71.4% | 0.05+170.6% | 0.02-74.5% | 0.07+177.2% | 0.03-13.8% | 0.03 |
| Total Income | 17.22-8.3% | 18.77+6.3% | 17.67+5.7% | 16.72+18.2% | 14.14-23.1% | 18.40+3.7% | 17.73 |
| EXPENSES | |||||||
| Expenditure | 16.47-8.1% | 17.92+5.7% | 16.95+3.5% | 16.38+18.7% | 13.80-21.6% | 17.60+3.6% | 16.99 |
| Tax | 0.70+685.9% | -0.12-163.1% | 0.19+64.8% | 0.12+621.3% | 0.02-93.4% | 0.24-0.4% | 0.24 |
| PROFIT | |||||||
| PBT | 0.75-12.6% | 0.85+19.7% | 0.71+111.0% | 0.34-1.1% | 0.34-57.1% | 0.80+7.4% | 0.74 |
| Net Profit | 0.04-95.5% | 0.98+86.0% | 0.52+134.8% | 0.22-31.6% | 0.33-41.3% | 0.56+11.2% | 0.50 |
| KEY METRICS | |||||||
| OPM % | 3.40%-2.15pp | 5.55%+0.66pp | 4.89%+1.75pp | 3.14%-0.04pp | 3.18%+0.15pp | 3.03%+0.13pp | 2.90% |
| NPM % | 0.25%-4.94pp | 5.19%+2.22pp | 2.97%+1.63pp | 1.34%-0.97pp | 2.31%-0.71pp | 3.02%+0.20pp | 2.82% |
| EPS | 0.04-96.0% | 1.01+87.0% | 0.54+134.8% | 0.23-32.4% | 0.34-40.4% | 0.57+9.6% | 0.52 |
Corporate Events
Board MeetingSANDUPHQ
202528May
Board Meeting
Request for reclassification from ‘Promoter Group’ category …
BSE Filing ↗ Board MeetingSANDUPHQ
202414Nov
Board Meeting
Approve Standalone and Consolidated Unaudited Financial Resu…
BSE Filing ↗